| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Nov 24 | PKBO Peak Bio | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 372,940 | 0.00 | 0 |
| 14 Nov 24 | PKBO Peak Bio | Common Stock | Sale back to company | Dispose D | No | No | 0 | 8,382,742 | 0.00 | 0 |
| 14 Nov 24 | PKBO Peak Bio | Common Stock | Sale back to company | Dispose D | No | No | 0 | 4,574,661 | 0.00 | 0 |
| 14 Nov 24 | PKBO Peak Bio | Common Stock | Conversion | Acquire C | No | No | 0 | 4,574,661 | 0.00 | 4,574,661 |
| 14 Nov 24 | PKBO Peak Bio | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.8 | 1,200,000 | 960.00 k | 0 |
| 14 Nov 24 | PKBO Peak Bio | Warrant (Right to Purchase) Common Stock | Sale back to company | Dispose D | No | No | 0.6 | 176,292 | 105.78 k | 0 |
| 13 Jun 24 | PLRX Pliant Therapeutics | Common Stock Common Stock | Grant | Acquire A | No | No | 13.06 | 26,764 | 349.54 k | 26,764 |
| 21 Sep 23 | PKBO Peak Bio | Common Stock | Buy | Acquire P | No | No | 0 | 45,000 | 0.00 | 8,382,742 |
| 20 Sep 23 | PKBO Peak Bio | Common Stock | Buy | Acquire P | No | No | 0 | 30,000 | 0.00 | 8,337,742 |
| 19 Sep 23 | PKBO Peak Bio | Common Stock | Buy | Acquire P | No | No | 0 | 50,000 | 0.00 | 8,307,742 |
